Anti-apolipoprotein A-1 autoantibodies as biomarker for atherosclerosis burden in patients with periodontitis

Journal of Periodontal Research

Volumn 48, Issue 3, 2013, Pages 350-356

  Wick, P A ^a   Mombelli, A ^a   Pagano, S ^b   Moren, X ^b   Giannopoulou, C ^a   Mach, F ^b   Roux Lombard, P ^b   Vuilleumier, N ^b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Ankle brachial index; Anti apolipoprotein A 1 autoantibodies; Atherosclerosis; Autoimmunity; Matrix metalloproteinases; Periodontitis

Indexed keywords

APOLIPOPROTEIN A1; ARGININE; AUTOANTIBODY; BIOLOGICAL MARKER; C REACTIVE PROTEIN; DIMETHYLARGININE; DRUG DERIVATIVE; IMMUNOGLOBULIN G; MATRIX METALLOPROTEINASE;

ADULT; ANKLE BRACHIAL INDEX; ARTICLE; ATHEROSCLEROSIS; BLOOD; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; CHRONIC PERIODONTITIS; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; NONPARAMETRIC TEST; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL MODEL;

ADULT; ANKLE BRACHIAL INDEX; APOLIPOPROTEIN A-I; ARGININE; ATHEROSCLEROSIS; AUTOANTIBODIES; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHRONIC PERIODONTITIS; FEMALE; HUMANS; IMMUNOGLOBULIN G; LOGISTIC MODELS; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; ROC CURVE; STATISTICS, NONPARAMETRIC;

EID: 84876786716     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/jre.12014     Document Type: Article

References (39)

1. Persson GR, Persson RE. Cardiovascular disease and periodontitis: an update on the associations and risk. J Clin Periodontol 2008;35(suppl 8):362-379.
2. Mattila KJ, Nieminen MS, Valtonen VV et al. Association between dental health and acute myocardial-infarction. Brit Med J 1989;298:779-781.
3. DeStefano F, Anda RF, Kahn HS, Williamson DF, Russell CM. Dental disease and risk of coronary heart-disease and mortality. Brit Med J 1993;306:688-691.
4. Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S. Periodontal disease and cardiovascular disease. J Periodontol 1996;67:1123-1137.
5. Buhlin K, Mantyla P, Paju S et al. Periodontitis is associated with angiographically verified coronary artery disease. J Clin Periodontol 2011;38:1007-1014.
6. Beck JD, Eke P, Heiss G et al. Periodontal disease and coronary heart disease - a reappraisal of the exposure. Circulation 2005;112:19-24.
7. Humphrey LL, Fu RW, Buckley DI, Freeman M, Helfand M. Periodontal disease and coronary heart disease incidence: a systematic review and meta-analysis. J Gen Intern Med 2008; 23: 2079-2086.
8. Bahekar AA, Singh S, Saha S, Molnar J, Arora R. The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis. Am Heart J 2007;154:830-837.
9. Dietrich T, Jimenez M, Kaye EAK, Vokonas PS, Garcia RI. Age-dependent associations between chronic periodontitis/edentulism and risk of coronary heart disease. Circulation 2008;117:1668-1674.
10. Friedewald VE, Kornman KS, Beck JD et al. The American Journal of Cardiology and Journal of Periodontology editors' consensus: periodontitis and atherosclerotic cardiovascular disease. J Periodontol 2009;80:1021-1032.
11. Higashi Y, Goto C, Jitsuiki D et al. Periodontal infection is associated with endothelial dysfunction in healthy subjects and hypertensive patients. Hypertension 2008;51:446-453.
12. Higashi Y, Goto C, Hidaka T et al. Oral infection-inflammatory pathway, periodontitis, is a risk factor for endothelial dysfunction in patients with coronary artery disease. Atherosclerosis 2009;206:604-610.
13. Roux-Lombard P, Pagano S, Montecucco F, Satta N, Vuilleumier N. Auto-antibodies as emergent prognostic markers and possible mediators of ischemic cardiovascular diseases. Clin Rev Allergy Immunol 2010;doi: 10.1007/s12016-010-8233-z. [Epub ahead of print].
14. Segovia M, Ganzinelli S, Reina S, Borda E, Sterin-Borda L. Role of anti-beta1 adrenergic antibodies from patients with periodontitis in cardiac dysfunction. J Oral Pathol Med 2012;41:242-248.
15. Hendler A, Mulli TK, Hughes FJ et al. Involvement of autoimmunity in the pathogenesis of aggressive periodontitis. J Dent Res 2010;89:1389-1394.
16. Buhlin K, Hultin M, Norderyd O et al. Risk factors for atherosclerosis in cases with severe periodontitis. J Clin Periodontol 2009;36:541-549.
17. Vuilleumier N, Bas S, Pagano S et al. Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis. Arthritis Rheum 2010;62:2640-2650.
18. Vuilleumier N, Rossier MF, Pagano S et al. Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction. Eur Heart J 2010;31:815-823.
19. Keller PF, Pagano S, Roux-Lombard P et al. Autoantibodies against apolipoprotein A-1 and phosphorylcholine for diagnosis of non-ST-segment elevation myocardial infarction. J Intern Med 2012;271:451-462.
20. Montecucco F, Vuilleumier N, Pagano S et al. Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability. Eur Heart J 2011;32:412-421.
21. Vuilleumier N, Pagano S, Lahlou K et al. Head-to-head comparison of auto-antibodies for cardiovascular outcome prediction after myocardial infarction: a prospective study. J Clinic Experiment Cardiol 2011;2:169.
22. Ouriel K, McDonnell AE, Metz CE, Zarins CK. Critical evaluation of stress testing in the diagnosis of peripheral vascular disease. Surgery 1982;91:686-693.
23. Megnien JL, Simon A, Gariepy J et al. Preclinical changes of extracoronary arterial structures as indicators of coronary atherosclerosis in men. J Hypertens 1998;16:157-163.
24. Fowkes FG, Murray GD, Butcher I et al. Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008;300:197-208.
25. Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP. The role of ankle brachial index and carotid intima-media thickness in vascular risk stratification. Curr Opin Cardiol 2010;25:394-398.
26. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004;109:III27-III32.
27. von Eckardstein A, Rohrer L. Transendothelial lipoprotein transport and regulation of endothelial permeability and integrity by lipoproteins. Curr Opin Lipidol 2009;20:197-205.
28. Cooke JP. Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol 2000; 20: 2032-2037.
29. Anderssohn M, Schwedhelm E, Luneburg N, Vasan RS, Boger RH. Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus. Diab Vasc Dis Res 2010;7:105-118.
30. Böger RH, Maas R, Schulze F, Schwedhelm E. Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality - an update on patient populations with a wide range of cardiovascular risk. Pharmacol Res 2009;60:481-487.
31. Ridker PM, Morrow DA. C-reactive protein, inflammation, and coronary risk. Cardiol Clin 2003;21:315-325.
32. Finckh A, Courvoisier DS, Pagano S et al. Evaluation of cardiovascular risk in patients with rheumatoid arthritis. Do cardiovascular biomarkers offer added predictive ability over established clinical risk scores? Arthritis Care Res (Hoboken) 2012;64:817-825.
33. Pagano S, Satta N, Werling D et al. Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex. J Intern Med 2012;272:344-357.
34. Rossier MF, Pagano S, Python M et al. Antiapolipoprotein A-1 IgG chronotropic effects require nongenomic action of aldosterone on L-type calcium channels. Endocrinology 2012;153:1269-1278.
35. Söder PO, Meurman JH, Jogestrand T, Nowak J, Söder B. Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in blood as markers for early atherosclerosis in subjects with chronic periodontitis. J Periodontal Res 2009;44:452-458.
36. Lopez Jornet P, JD B-M, Berna-Serna J, Camacho-Alonso F, Fernandez-Millan S, Reus-Pintado M. Measurement of atherosclerosis markers in patients with periodontitis: a case-control study. J Periodontol 2012;83:690-698.
37. Loo WT, Wang M, Jin LJ, Cheung MN, Li GR. Association of matrix metalloproteinase (MMP-1, MMP-3 and MMP-9) and cyclooxygenase-2 gene polymorphisms and their proteins with chronic periodontitis. Arch Oral Biol 2011;56:1081-1090.
38. Blankenberg S, Rupprecht HJ, Poirier O et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 2003;107:1579-1585.
39. Paraskevas S, Huizinga JD, Loos BG. A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol 2008;35:277-290.